Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19
Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. The material for the study was obtained from the database of the TARGE...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2023-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3467 |
| _version_ | 1827063665637982208 |
|---|---|
| author | N. P. Kutishenko M. M. Lukyanov S. Yu. Martsevich A. A. Pulin E. Yu. Andreenko V. P. Voronina V. A. Dindikova N. A. Dmitrieva M. M. Kudryavtseva O. V. Lerman A. N. Makoveeva E. Yu. Okshina А. А. Smirnov E. N. Belova V. G. Klyashtorny E. V. Kudryashov O. E. Karpov O. M. Drapkina |
| author_facet | N. P. Kutishenko M. M. Lukyanov S. Yu. Martsevich A. A. Pulin E. Yu. Andreenko V. P. Voronina V. A. Dindikova N. A. Dmitrieva M. M. Kudryavtseva O. V. Lerman A. N. Makoveeva E. Yu. Okshina А. А. Smirnov E. N. Belova V. G. Klyashtorny E. V. Kudryashov O. E. Karpov O. M. Drapkina |
| author_sort | N. P. Kutishenko |
| collection | DOAJ |
| description | Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. The material for the study was obtained from the database of the TARGET-VIP inhospital registry. The registry included 1130 people. Of 863 patients discharged from the hospital with a diagnosis of COVID-19, 473 (548%) patients with CVD were selected, and 31 (40,8%) patients were selected from 76 patients in whom the diagnosis of COVID-19 was not confirmed with CVD.Results. At the stage of discharge from the hospital, the quality of therapy for CVD was insufficient on average, the frequency of proper prescriptions was 59,5%. During the first year, there was a significant trend towards a decrease in the prevalence of antihypertensive therapy for hypertension (p=0,018), anticoagulants for atrial fibrillation (p<0,001) and an increase in prescribing angiotensinconverting enzyme inhibitors/angiotensin receptor blockers for heart failure (p=0,037). The average prevalence of prescribing proper cardiovascular pharmacotherapy after 30-60 days and 6 months of follow-up was significantly less than at discharge from the hospital. In both groups of patients, when comparing the average frequency of compliance with proper prescriptions at all follow-up periods, as well as when comparing these indicators between groups, no significant differences were found, with the exception of the stage of 30-60 days after discharge from the hospital (p=0,009).Conclusion. In the TARGET-VIP registry after discharge from the hospital, the prevalence of proper appointments for CVD was insufficient. During the first year of observation, patients with CVD showed a significant decrease in the frequency of proper prescription of antihypertensive therapy for hypertension and anticoagulants for atrial fibrillation. When comparing groups of patients with confirmed and non-confirmed COVID-19, a higher average rate of adherence to proper prescriptions was found in patients with confirmed COVID-19. However, significant differences were found only 30-60 days after discharge. |
| first_indexed | 2024-04-10T03:33:21Z |
| format | Article |
| id | doaj.art-bc957a2b07cf4c4fb61273111532e7ed |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:34:52Z |
| publishDate | 2023-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-bc957a2b07cf4c4fb61273111532e7ed2024-10-17T12:21:43Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252023-01-01211210.15829/1728-8800-2022-34672596Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19N. P. Kutishenko0M. M. Lukyanov1S. Yu. Martsevich2A. A. Pulin3E. Yu. Andreenko4V. P. Voronina5V. A. Dindikova6N. A. Dmitrieva7M. M. Kudryavtseva8O. V. Lerman9A. N. Makoveeva10E. Yu. Okshina11А. А. Smirnov12E. N. Belova13V. G. Klyashtorny14E. V. Kudryashov15O. E. Karpov16O. M. Drapkina17National Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicinePirogov National Medical and Surgical CenterNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicinePirogov National Medical and Surgical CenterNational Medical Research Center for Therapy and Preventive MedicineAim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. The material for the study was obtained from the database of the TARGET-VIP inhospital registry. The registry included 1130 people. Of 863 patients discharged from the hospital with a diagnosis of COVID-19, 473 (548%) patients with CVD were selected, and 31 (40,8%) patients were selected from 76 patients in whom the diagnosis of COVID-19 was not confirmed with CVD.Results. At the stage of discharge from the hospital, the quality of therapy for CVD was insufficient on average, the frequency of proper prescriptions was 59,5%. During the first year, there was a significant trend towards a decrease in the prevalence of antihypertensive therapy for hypertension (p=0,018), anticoagulants for atrial fibrillation (p<0,001) and an increase in prescribing angiotensinconverting enzyme inhibitors/angiotensin receptor blockers for heart failure (p=0,037). The average prevalence of prescribing proper cardiovascular pharmacotherapy after 30-60 days and 6 months of follow-up was significantly less than at discharge from the hospital. In both groups of patients, when comparing the average frequency of compliance with proper prescriptions at all follow-up periods, as well as when comparing these indicators between groups, no significant differences were found, with the exception of the stage of 30-60 days after discharge from the hospital (p=0,009).Conclusion. In the TARGET-VIP registry after discharge from the hospital, the prevalence of proper appointments for CVD was insufficient. During the first year of observation, patients with CVD showed a significant decrease in the frequency of proper prescription of antihypertensive therapy for hypertension and anticoagulants for atrial fibrillation. When comparing groups of patients with confirmed and non-confirmed COVID-19, a higher average rate of adherence to proper prescriptions was found in patients with confirmed COVID-19. However, significant differences were found only 30-60 days after discharge.https://cardiovascular.elpub.ru/jour/article/view/3467cardiovascular diseasecovid-19registryprospective follow-updrug treatment |
| spellingShingle | N. P. Kutishenko M. M. Lukyanov S. Yu. Martsevich A. A. Pulin E. Yu. Andreenko V. P. Voronina V. A. Dindikova N. A. Dmitrieva M. M. Kudryavtseva O. V. Lerman A. N. Makoveeva E. Yu. Okshina А. А. Smirnov E. N. Belova V. G. Klyashtorny E. V. Kudryashov O. E. Karpov O. M. Drapkina Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 Кардиоваскулярная терапия и профилактика cardiovascular disease covid-19 registry prospective follow-up drug treatment |
| title | Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
| title_full | Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
| title_fullStr | Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
| title_full_unstemmed | Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
| title_short | Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
| title_sort | medical treatment of patients with cardiovascular diseases during the first year after hospitalization for covid 19 |
| topic | cardiovascular disease covid-19 registry prospective follow-up drug treatment |
| url | https://cardiovascular.elpub.ru/jour/article/view/3467 |
| work_keys_str_mv | AT npkutishenko medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT mmlukyanov medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT syumartsevich medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT aapulin medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT eyuandreenko medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT vpvoronina medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT vadindikova medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT nadmitrieva medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT mmkudryavtseva medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT ovlerman medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT anmakoveeva medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT eyuokshina medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT aasmirnov medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT enbelova medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT vgklyashtorny medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT evkudryashov medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT oekarpov medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 AT omdrapkina medicaltreatmentofpatientswithcardiovasculardiseasesduringthefirstyearafterhospitalizationforcovid19 |